Nosha Farhadfar

2.9k total citations
49 papers, 318 citations indexed

About

Nosha Farhadfar is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Nosha Farhadfar has authored 49 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 20 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Nosha Farhadfar's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (11 papers). Nosha Farhadfar is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (11 papers). Nosha Farhadfar collaborates with scholars based in United States, Australia and Spain. Nosha Farhadfar's co-authors include John R. Wingard, Mark R. Litzow, Hemant S. Murthy, W. Stratford May, Ying Li, Sonia Cerquozzi, Ayalew Tefferi, William J. Hogan, Jiang Bian and Jack W. Hsu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nosha Farhadfar

38 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nosha Farhadfar United States 11 188 111 93 67 52 49 318
Maxim Norkin United States 12 231 1.2× 148 1.3× 41 0.4× 86 1.3× 52 1.0× 35 396
Yoo Jin Lee South Korea 10 185 1.0× 77 0.7× 69 0.7× 83 1.2× 59 1.1× 50 334
Jiann-Shiuh Chen Taiwan 10 121 0.6× 51 0.5× 124 1.3× 96 1.4× 46 0.9× 23 356
Maria Åström Sweden 11 217 1.2× 81 0.7× 152 1.6× 65 1.0× 68 1.3× 22 306
Rebeca Rodríguez‐Veiga Spain 10 171 0.9× 117 1.1× 45 0.5× 147 2.2× 49 0.9× 39 326
Teresa Lerede Italy 11 191 1.0× 76 0.7× 184 2.0× 38 0.6× 34 0.7× 26 289
G Geissler Germany 8 388 2.1× 97 0.9× 88 0.9× 46 0.7× 52 1.0× 10 487
Francisco J. Márquez‐Malaver Spain 9 171 0.9× 68 0.6× 40 0.4× 47 0.7× 39 0.8× 21 266
Katalin Csordás Hungary 11 76 0.4× 86 0.8× 159 1.7× 53 0.8× 31 0.6× 21 329
Min Ruan China 8 185 1.0× 71 0.6× 86 0.9× 96 1.4× 29 0.6× 66 303

Countries citing papers authored by Nosha Farhadfar

Since Specialization
Citations

This map shows the geographic impact of Nosha Farhadfar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nosha Farhadfar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nosha Farhadfar more than expected).

Fields of papers citing papers by Nosha Farhadfar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nosha Farhadfar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nosha Farhadfar. The network helps show where Nosha Farhadfar may publish in the future.

Co-authorship network of co-authors of Nosha Farhadfar

This figure shows the co-authorship network connecting the top 25 collaborators of Nosha Farhadfar. A scholar is included among the top collaborators of Nosha Farhadfar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nosha Farhadfar. Nosha Farhadfar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farhadfar, Nosha, Najla El Jurdi, Heidi Chen, et al.. (2025). Reproducibility and repeatability of the Myoton to quantify sclerotic chronic graft-versus-host disease. Blood Advances. 10(4). 1145–1152.
2.
Wingard, John R., Ji‐Hyun Lee, Zeina Al‐Mansour, et al.. (2025). Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia. Journal of Clinical Oncology. 44(4). 300–310.
3.
4.
Choe, Hannah, Amandeep Salhotra, Nosha Farhadfar, et al.. (2024). Dynamics of Overall and Organ-Specific Responses to Axatilimab in Chronic Graft-Versus-Host Disease: Analysis from the Agave-201 Study. Blood. 144(Supplement 1). 98–98.
5.
Cline, Christina, Zeina Al‐Mansour, Ji‐Hyun Lee, et al.. (2024). A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia. Leukemia & lymphoma. 65(10). 1502–1510.
6.
Hamilton, Betty K., Lynn Onstad, Paul A. Carpenter, et al.. (2024). Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host Disease. Contemporary Clinical Trials. 145. 107637–107637.
7.
Weaver, Michael T., John R. Wingard, Phoebe D. Williams, et al.. (2024). A liberalized diet does not improve caloric intake during neutropenia in patients undergoing hematopoietic stem cell transplants: A prospective randomized controlled trial. Nutrition in Clinical Practice. 40(3). 584–595.
8.
Pidala, Joseph, Paul A. Carpenter, Lynn Onstad, et al.. (2024). Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH). PLoS ONE. 19(5). e0298026–e0298026. 4 indexed citations
9.
Williams, Kirsten M., Nancy Gillis, Kelly L. Bolton, et al.. (2023). Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(3). 255–267. 10 indexed citations
10.
Murthy, Guru Subramanian Guru, Brent R. Logan, Amer Beitinjaneh, et al.. (2023). Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia. American Journal of Hematology. 98(4). 608–619. 10 indexed citations
11.
Kelly, Debra Lynch, Wendy J. Dahl, James Colee, et al.. (2023). Physical Activity Compliance to American Cancer Society Recommendations Amongst Hematopoietic Stem Cell Transplant Survivors. Hematology/Oncology and Stem Cell Therapy. 16(4). 358–365.
12.
Farhadfar, Nosha, Michael T. Weaver, Zeina Al‐Mansour, et al.. (2022). Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors. Transplantation and Cellular Therapy. 28(9). 606.e1–606.e8. 4 indexed citations
13.
Farhadfar, Nosha, Helen Leather, Shu Wang, et al.. (2021). Severity of Acute Graft-Versus-Host Disease and Associated Healthcare Resource Utilization, Cost and Outcomes. Transplantation and Cellular Therapy. 27(3). S23–S23. 1 indexed citations
14.
Farhadfar, Nosha, Raad Z. Gharaibeh, Debra Lyon, et al.. (2021). Microbiota phylogenic analysis revealed decreased abundance of Faecalibacterium prausnitzii, an anti-inflammatory commensal bacterium, in patients with chronic graft-versus-host disease. Hematology/Oncology and Stem Cell Therapy. 14(3). 263–265. 4 indexed citations
15.
Murthy, Hemant S., Raad Z. Gharaibeh, Zeina Al‐Mansour, et al.. (2020). Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(11). 2001–2010. 11 indexed citations
16.
Farhadfar, Nosha, et al.. (2020). Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia. Hematology/Oncology and Stem Cell Therapy. 14(3). 246–251. 28 indexed citations
17.
Farhadfar, Nosha, Linda J. Burns, Tatenda Mupfudze, et al.. (2020). Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023. Transplantation and Cellular Therapy. 27(2). 183.e1–183.e7. 4 indexed citations
18.
Lutfi, Forat, William Paul Skelton, Yu Wang, et al.. (2019). Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients. Hematology/Oncology and Stem Cell Therapy. 13(1). 23–31. 9 indexed citations
19.
Lutfi, Forat, William Paul Skelton, Nosha Farhadfar, et al.. (2017). Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center. Blood. 130. 4529–4529. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maxim Norkin Breakdown of academic impact, for papers by Yoo Jin Lee Breakdown of academic impact, for papers by Jiann-Shiuh Chen Breakdown of academic impact, for papers by Maria Åström Breakdown of academic impact, for papers by Rebeca Rodríguez‐Veiga Breakdown of academic impact, for papers by Teresa Lerede Breakdown of academic impact, for papers by G Geissler Breakdown of academic impact, for papers by Francisco J. Márquez‐Malaver Breakdown of academic impact, for papers by Katalin Csordás Breakdown of academic impact, for papers by Min Ruan
Rankless by CCL
2026